Devicemakers Respond to Investigations, Improve Their Transparency

In response to industrywide investigations into financial relationships between doctors and medical device companies, some firms are ramping up their efforts to create more transparency.

In the wake of three whistle-blower suits involving promotion of off-label device uses, Medtronic disclosed information in a registry on its website last month about more than $1 million it donated to customers and affiliated groups between May and July.

In a similar move, Zimmer Holdings changed its sales practices this past spring following a $310 million civil settlement reached last year between a U.S. attorney and five orthopedic companies.

SOURCE: FDANEWS